{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T18:15:41Z","timestamp":1789150541401,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T00:00:00Z","timestamp":1549411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Daiichi Sankyo Co., Ltd."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s40261-019-00756-x","type":"journal-article","created":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T10:46:36Z","timestamp":1549449996000},"page":"369-377","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Efficacy and Safety of Loxoprofen Hydrogel Transdermal\u00a0Patch Versus Loxoprofen Tablet in Chinese Patients with Myalgia: A Double-Blind, Double-Dummy, Parallel-Group, Randomized, Controlled, Non-Inferiority Trial"],"prefix":"10.1007","volume":"39","author":[{"given":"Dongbao","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoxian","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengwu","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guochun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiguo","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeqing","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanguo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,6]]},"reference":[{"key":"756_CR1","first-page":"311","volume":"22","author":"S Sachiko","year":"2006","unstructured":"Sachiko S, Akio T, Mamoru T, Yoshikatsu K, Yukio I, Yoshio I, et al. Evaluation of administration frequency of LX-A in patients with osteoarthritis of the knee-randomized, open-label study compared between once-daily administration and twice-daily administration. J Clin Ther Med. 2006;22:311\u201326.","journal-title":"J Clin Ther Med."},{"key":"756_CR2","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1136\/ard.2010.128660","volume":"70","author":"G Burmester","year":"2011","unstructured":"Burmester G, Lanas A, Biasucci L, Hermann M, Lohmander S, Olivieri I, et al. The appropriate use of non-steroidal anti-inflammatory drugs in rheumatic disease: opinions of a multidisciplinary European expert panel. Ann Rheum Dis. 2011;70:818\u201322.","journal-title":"Ann Rheum Dis."},{"key":"756_CR3","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/acr.21596","volume":"64","author":"MC Hochberg","year":"2012","unstructured":"Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, McGowan J, et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res. 2012;64:465\u201374.","journal-title":"Arthritis Care Res."},{"key":"756_CR4","doi-asserted-by":"crossref","unstructured":"Massey T, Derry S, Moore RA, McQuay HJ. Topical NSAIDs for acute pain in adults. Cochrane Database Syst Rev. 2010;CD007402.","DOI":"10.1002\/14651858.CD007402.pub2"},{"key":"756_CR5","first-page":"1061","volume":"11","author":"N Moore","year":"2015","unstructured":"Moore N, Pollack C, Butkerait P. Adverse drug reactions and drug-drug interactions with over-the-counter NSAIDs. Ther Clin Risk Manag. 2015;11:1061\u201375.","journal-title":"Ther Clin Risk Manag."},{"key":"756_CR6","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1016\/j.semarthrit.2015.11.007","volume":"45","author":"F Rannou","year":"2016","unstructured":"Rannou F, Pelletier J-P, Martel-Pelletier J. Efficacy and safety of topical NSAIDs in the management of osteoarthritis: evidence from real-life setting trials and surveys. Semin Arthritis Rheum. 2016;45:S18\u201321.","journal-title":"Semin Arthritis Rheum."},{"key":"756_CR7","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.semarthrit.2015.11.010","volume":"45","author":"O Bruy\u00e8re","year":"2016","unstructured":"Bruy\u00e8re O, Cooper C, Pelletier J-P, Maheu E, Rannou F, Branco J, et al. A consensus statement on the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) algorithm for the management of knee osteoarthritis\u2014from evidence-based medicine to the real-life setting. Semin Arthritis Rheum. 2016;45:S3\u201311.","journal-title":"Semin Arthritis Rheum."},{"key":"756_CR8","unstructured":"Pubchem. Loxoprofen [Internet]. [cited 2018 Sep 10]. Available from: \n                    https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/3965\n                    \n                  ."},{"key":"756_CR9","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1002\/jps.20451","volume":"94","author":"T-S Koo","year":"2005","unstructured":"Koo T-S, Kim D-H, Ahn S-H, Kim K-P, Kim I-W, Seo S-Y, et al. Comparison of pharmacokinetics of loxoprofen and its active metabolites after an intravenous, intramuscular, and oral administration of loxoprofen in rats: evidence for extrahepatic metabolism. J Pharm Sci. 2005;94:2187\u201397.","journal-title":"J Pharm Sci."},{"key":"756_CR10","doi-asserted-by":"crossref","unstructured":"Derry S, Moore RA, Rabbie R. Topical NSAIDs for chronic musculoskeletal pain in adults. Cochrane Database Syst Rev. 2012;CD007400.","DOI":"10.1002\/14651858.CD007400.pub2"},{"key":"756_CR11","first-page":"293","volume":"22","author":"S Sugwara","year":"2006","unstructured":"Sugwara S, Tateishi A, Tanaka M, Kuroki Y, Inoue Y, Iwasaki Y, et al. A dose finding study of a hydrogel patch containing loxoprofen sodium in patients with osteoarthritis of the knee (Late Phase II Clinical Study). J Clin Ther Med. 2006;22:293\u2013310.","journal-title":"J Clin Ther Med."},{"key":"756_CR12","first-page":"393","volume":"22","author":"S Sachiko","year":"2006","unstructured":"Sachiko S, Yoshikatsu K, Akio T, Mamoru T, Yukio I, Yoshio I, et al. The effects of LOXONIN PAP 100\u00a0mg (hydrogel patch containing loxoprofen sodium) for the treatment of patients with osteoarthritis of the knee-randomized, double-blind clinical study with loxoprofen sodium tablets. J Clin Ther Med. 2006;22:393\u2013409.","journal-title":"J Clin Ther Med."},{"key":"756_CR13","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1002\/acr.21747","volume":"64","author":"F Tubach","year":"2012","unstructured":"Tubach F, Ravaud P, Martin-Mola E, Awada H, Bellamy N, Bombardier C, et al. Minimum clinically important improvement and patient acceptable symptom state in pain and function in rheumatoid arthritis, ankylosing spondylitis, chronic back pain, hand osteoarthritis, and hip and knee osteoarthritis: results from a prospective multinational study. Arthritis Care Res. 2012;64:1699\u2013707.","journal-title":"Arthritis Care Res."},{"key":"756_CR14","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10067-014-2701-4","volume":"35","author":"R Mu","year":"2016","unstructured":"Mu R, Bao C, Chen Z, Zheng Y, Wang G, Zhao D, et al. Efficacy and safety of loxoprofen hydrogel patch versus loxoprofen tablet in patients with knee osteoarthritis: a randomized controlled non-inferiority trial. Clin Rheumatol. 2016;35:165\u201373.","journal-title":"Clin Rheumatol."},{"key":"756_CR15","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1017\/S026502150600007X","volume":"23","author":"J-U Schreiber","year":"2006","unstructured":"Schreiber J-U, Mencke T, Pradarutti S, Jeblick S, Fuchs-Buder T. Does preoperatively administered parecoxib prevent succinylcholine-associated myalgia? A randomized, placebo-controlled trial. Eur J Anaesthesiol. 2006;23:332\u20137.","journal-title":"Eur J Anaesthesiol."},{"key":"756_CR16","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.jpain.2005.12.010","volume":"7","author":"SP Cohen","year":"2006","unstructured":"Cohen SP, Verdolin MH, Chang AS, Kurihara C, Morlando BJ, Mao J. The intravenous ketamine test predicts subsequent response to an oral dextromethorphan treatment regimen in fibromyalgia patients. J Pain. 2006;7:391\u20138.","journal-title":"J Pain."},{"key":"756_CR17","first-page":"S19","volume":"62","author":"RD Gerwin","year":"2013","unstructured":"Gerwin RD. Diagnosing fibromyalgia and myofascial pain syndrome: a guide. J Fam Pract. 2013;62:S19\u201325.","journal-title":"J Fam Pract."},{"issue":"1","key":"756_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/1756-185X.12064","volume":"16","author":"B Zhao","year":"2013","unstructured":"Zhao B, Shi Y, Li Z. Effectiveness and safety of hydrogel patches containing loxoprofen sodium in patients with myalgia: a randomized, controlled, double-blind, double-parallel, multicenter phase 3 trial [abstract no. APLAR-0134]. Int J Rheum Dis. 2013;16(1):1\u2013122.","journal-title":"Int J Rheum Dis."},{"issue":"1","key":"756_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/1756-185X.12064","volume":"16","author":"H Zhang","year":"2013","unstructured":"Zhang H, Lin J, Sun T. Double-blind, multicenter trial to evaluate safety and efficacy of hydrogel patch containing loxoprofen-sodium in treating swelling and pain caused by trauma [abstract no. APLAR-0153]. Int J Rheum Dis. 2013;16(1):1\u2013122.","journal-title":"Int J Rheum Dis"},{"key":"756_CR20","first-page":"411","volume":"22","author":"S Sugawara","year":"2006","unstructured":"Sugawara S, Kuroki Y, Tanaka M, et al. The effects of Loxonin Pap 100\u00a0mg (hydrogel patch containing loxoprofen sodium) for the treatment of myalgia: randomized, double-blind study compared with loxoprofen sodium tablets. J Clin Ther Med. 2006;22:411\u201326.","journal-title":"J Clin Ther Med."},{"key":"756_CR21","first-page":"427","volume":"22","author":"S Sugawara","year":"2006","unstructured":"Sugawara S, Iwasaki Y, Aoki T. The Effects of LOXONIN PAP 100\u00a0mg (hydrogel patch containing loxoprofen sodium) for the treatment of swelling or pain following injuries-randomized, double-blind study with loxoprofen sodium tablet. J Clin Ther Med. 2006;22:427\u201342.","journal-title":"J Clin Ther Med."},{"issue":"1","key":"756_CR22","first-page":"55","volume":"23","author":"S Sugawara","year":"2007","unstructured":"Sugawara S, Nobuoka F, Ogawa D, et al. Clinical efficacy of the hydrogel patch containing loxoprofen sodium (LX-A) on osteoarthritis of the knee: a randomized, open label clinical study with ketoprofen patch (phase III therapeutic confirmatory study) [Japanese with English abstract]. J Clin Ther Med. 2007;23(1):55\u201371.","journal-title":"J Clin Ther Med"},{"issue":"2","key":"756_CR23","first-page":"127","volume":"23","author":"S Sugawara","year":"2007","unstructured":"Sugawara S, Nobuoka F, Ogawa D, et al. Clinical efficacy of the hydrogel patch containing loxoprofen sodium (LX-A) on myalgia: a randomized, open label clinical study compared with indometacin patch (phase III therapeutic confirmatory study) [Japanese with English abstract]. J Clin Ther Med. 2007;23(2):127\u201341.","journal-title":"J Clin Ther Med."},{"key":"756_CR24","first-page":"227","volume":"26","author":"H Mizutani","year":"2010","unstructured":"Mizutani H, Miyano F, Uozu A. Drug use result survey of Loxonin Pap (hydrogel patch containing loxoprofen sodium hydrate). J Clin Ther Med. 2010;26:227\u201340.","journal-title":"J Clin Ther Med."},{"key":"756_CR25","first-page":"727","volume":"26","author":"H Mizutani","year":"2010","unstructured":"Mizutani H, Miyano F, Uozu A. Drug use result survey of Loxonin Tape (patch containing loxoprofen sodium hydrate). J Clin Ther Med. 2010;26:727\u201341.","journal-title":"J Clin Ther Med."},{"issue":"6","key":"756_CR26","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/bdd.1945","volume":"36","author":"R Sawamura","year":"2015","unstructured":"Sawamura R, Sakurai H, Wada N, Nishiya Y, Honda T, Kazui M, et al. Bioactivation of loxoprofen to a pharmacologically active metabolite and its disposition kinetics in human skin. Biopharm Drug Dispos. 2015;36(6):352\u201363.","journal-title":"Biopharm Drug Dispos."},{"key":"756_CR27","first-page":"74","volume":"70","author":"R Sawamura","year":"2015","unstructured":"Sawamura R, Kazui M, Kurihara A, Izumi T. Pharmacokinetics of loxoprofen and its active metabolite after dermal application of loxoprofen gel to rats. Pharm. 2015;70:74\u201380.","journal-title":"Pharm."},{"key":"756_CR28","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1097\/MCG.0000000000000432","volume":"50","author":"JM Scheiman","year":"2016","unstructured":"Scheiman JM. NSAID-induced gastrointestinal injury: a focused update for clinicians. J Clin Gastroenterol. 2016;50:5\u201310.","journal-title":"J Clin Gastroenterol."},{"key":"756_CR29","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1161\/CIRCULATIONAHA.106.181424","volume":"115","author":"EM Antman","year":"2007","unstructured":"Antman EM, Bennett JS, Daugherty A, Furberg C, Roberts H, Taubert KA, et al. Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. Circulation. 2007;115:1634\u201342.","journal-title":"Circulation."},{"key":"756_CR30","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1056\/NEJM199906173402407","volume":"340","author":"MM Wolfe","year":"1999","unstructured":"Wolfe MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med. 1999;340:1888\u201399.","journal-title":"N Engl J Med."}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40261-019-00756-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-019-00756-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-019-00756-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T13:37:15Z","timestamp":1583501835000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40261-019-00756-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,6]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["756"],"URL":"https:\/\/doi.org\/10.1007\/s40261-019-00756-x","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,6]]},"assertion":[{"value":"6 February 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The study protocol and research manual were approved by the Ethics Committees of all institutions involved. Written informed consent was obtained from all subjects in accordance with the Declaration of Helsinki principles and the guidelines for Good Clinical Practice of the International Conference on Harmonization.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The data sets used and\/or analyzed during the current study are available from the corresponding author on reasonable request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and materials"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was funded by Daiichi Sankyo Co., Ltd.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}}]}}